GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Net Income Including Noncontrolling Interests

Nanjing Pharmaceutical Co (SHSE:600713) Net Income Including Noncontrolling Interests : ¥726 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Nanjing Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥197 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥726 Mil.


Nanjing Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Nanjing Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 431.55 470.04 610.55 715.92 712.81

Nanjing Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.61 192.19 157.17 179.84 196.95

Nanjing Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥726 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Nanjing Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Pharmaceutical Co (SHSE:600713) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Executives
Xiao Hong senior management
Peng Yu Ping senior management
She Ping Supervisors
Jiang Xiao Jun senior management
Teng Xue Wu senior management
Zhou Jian Jun senior management
Li Yi Director
Huang Yan Li Supervisors
Tang Jian Zhong senior management
Zhang Yan Hui senior management
Zhou Yao Ping Director
Wang Hui Qing senior management
He Jin Geng senior management
Ding Feng Jun Director
Liang Yu Tang Director

Nanjing Pharmaceutical Co (SHSE:600713) Headlines

No Headlines